Chemomab Therapeutics Ltd. Current Liabilities
Chemomab Therapeutics Ltd. (CMMB) had Current Liabilities of $1.48 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-03-23
- 2025-12-31: Liabilities, Current $1.48M.
- 2025-06-30: Liabilities, Current $1.43M.
- 2024-12-31: Liabilities, Current $3.22M.
- 2024-06-30: Liabilities, Current $4.31M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $1.48M 20-F · filed 2026-03-23 | |
| 2025-06-30 | $1.43M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $3.22M 20-F · filed 2026-03-23 | |
| 2024-06-30 | $4.31M 6-K · filed 2024-08-21 | |
| 2023-12-31 | $4.84M 20-F · filed 2025-04-04 | |
| 2023-06-30 | $6.83M 6-K · filed 2023-08-14 | |
| 2023-03-31 | $7.00M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $6.75M 20-F · filed 2024-03-28 | |
| 2022-09-30 | $5.48M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $4.39M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $3.52M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.65M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $1.63M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $2.16M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $4.63M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.32M 10-K · filed 2022-03-30 | $2.59M 10-K · filed 2021-03-09 |
| 2020-09-30 | $2.27M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.75M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $3.47M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $4.12M 10-K · filed 2021-03-09 | |
| 2018-12-31 | $2.75M 10-K · filed 2020-03-17 |